ML20249B857
| ML20249B857 | |
| Person / Time | |
|---|---|
| Issue date: | 06/23/1998 |
| From: | Hoyle J NRC OFFICE OF THE SECRETARY (SECY) |
| To: | Callan L NRC OFFICE OF THE EXECUTIVE DIRECTOR FOR OPERATIONS (EDO) |
| References | |
| REF-10CFR9.7 M980617B, SECY-98-127-C, SECY-98-128-C, NUDOCS 9806240330 | |
| Download: ML20249B857 (1) | |
Text
,
/ % UNITED STATES y ,,
NUCLEAR REGULATORY COMMISSION g g WASHINGTON, D.C. 2055 5 0001
'l IN RESPONSE, PLEASE
,,,,, June 23, 1998 REFER TO M980617B SECRETARY MEMORANDUM TO: L. Joseph Callan Exec iv Dire or for Operations l
FROM: Joh . Ho'e W
SUBJECT:
STAFF REQUIREMENTS: MEETING WITH THE ADVISORY COMMITTEE ON MEDICAL USES OF ISOTOPES (ACMUI) AND BRIEFING ON PART 35 QM RULE,2:05 P.M. WEDNESDAY, JUNE 17,1998, COMMISSIONERS CONFERENCE ROOM, ONE WHITE FLINT NORTH, ROCKVILLE, MARYLAND (OPEN TO PUBliC ATTENDANCE)
The Commission was briefed by the NRC staff and members of the Advisory Committee on Medical Uses of isotopes on the staff's proposed policy statement on the medical use of byproduct material, as cor kined in SECY 98-127, and proposed amendments to 10 CFR part 35," Medical Use of Byproduct Material, as contained in SECY 08-128. There were no requirements identified for staff action. The Commission indicated that it wou'd provide guidance on the issues discussed during the meeting in the context of Commission consideration of SECY- 98-127 and SECY-98-128, i
i cc: Chairman Jackson o Commissioner Dieus Commissioner Diaz
- M,Q] ) C Commissioner McGaffigan 10 Q [Y]-
CFO OlG OCA OPA Office directors, regions, ACRS, ACNW, ASLBP (by E-Mail)
PCR DOS 9806240330 980623 PDR 10CFR PT9.7 pog a_
) OC FT(2.
i